Quoc M.'s Colleagues at QED Therapeutics
Quoc M.'s Contact Details
HQ
650-231-4088
650-231-4088
Location
Company
QED Therapeutics
QED Therapeutics
Quoc M.'s Company Details
QED Therapeutics, a subsidiary of BridgeBio Pharma, is a biotechnology company focused on precision medicine for FGFR-driven disorders. Our lead candidate is infigratinib, a best-in-class FGFR kinase inhibitor that has shown meaningful clinical activity in chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions. QED is also evaluating infigratinib in preclinical studies for the treatment of achondroplasia. We plan to develop infigratinib in additional FGFR-driven tumor types and rare disorders.
Frequently Asked Questions about Quoc M.
Quoc M. currently works for QED Therapeutics.
Quoc M.'s role at QED Therapeutics is Director, Head of Statistical Programming.
Quoc M.'s email address is ***@qedtx.com. To view Quoc M.'s full email address, please signup to ConnectPlex.
Quoc M. works in the Biotechnology industry.
Quoc M.'s colleagues at QED Therapeutics are Ai Li, Craig Berman, Elena Muslimova, Dan Mulreany, Robyn Leary, Greg Troupe, Terry Cho and others.
Quoc M.'s phone number is 650-231-4088